Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.

Kooistra M, Geerlings MI, van der Graaf Y, Mali WP, Vincken KL, Kappelle LJ, Muller M, Biessels GJ; SMART-MR Study Group.

Neurobiol Aging. 2014 Jan;35(1):35-41. doi: 10.1016/j.neurobiolaging.2013.07.004. Epub 2013 Aug 7.

2.

Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study.

Geerlings MI, Appelman AP, Vincken KL, Mali WP, van der Graaf Y; SMART Study Group.

Am J Epidemiol. 2009 Nov 1;170(9):1147-55. doi: 10.1093/aje/kwp256. Epub 2009 Sep 25.

PMID:
19783584
3.

Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2012 Nov 13;79(20):2029-36. doi: 10.1212/WNL.0b013e3182749f02. Epub 2012 Oct 31.

PMID:
23115210
4.

Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.

Jochemsen HM, Kloppenborg RP, de Groot LC, Kampman E, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Alzheimers Dement. 2013 May;9(3):302-9. doi: 10.1016/j.jalz.2011.11.008. Epub 2012 Aug 3.

PMID:
22863909
5.

White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.

Appelman AP, Vincken KL, van der Graaf Y, Vlek AL, Witkamp TD, Mali WP, Geerlings MI; SMART Study Group.

Cerebrovasc Dis. 2010;29(1):28-35. doi: 10.1159/000255971. Epub 2009 Nov 5.

PMID:
19893309
6.

Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.

Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, van der Graaf Y; SMART Study Group.

Atherosclerosis. 2010 May;210(1):130-6. doi: 10.1016/j.atherosclerosis.2009.10.039. Epub 2009 Nov 10.

PMID:
19945704
7.

Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study.

Kooistra M, Geerlings MI, Mali WP, Vincken KL, van der Graaf Y, Biessels GJ; SMART-MR Study Group.

J Neurol Sci. 2013 Sep 15;332(1-2):69-74. doi: 10.1016/j.jns.2013.06.019. Epub 2013 Jul 6.

8.

Physical activity, structural brain changes and cognitive decline. The SMART-MR study.

Kooistra M, Boss HM, van der Graaf Y, Kappelle LJ, Biessels GJ, Geerlings MI; SMART-MR Study Group.

Atherosclerosis. 2014 May;234(1):47-53. doi: 10.1016/j.atherosclerosis.2014.02.003. Epub 2014 Feb 20.

PMID:
24607853
9.

Brain atrophy and cognition: interaction with cerebrovascular pathology?

Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI.

Neurobiol Aging. 2011 May;32(5):885-93. doi: 10.1016/j.neurobiolaging.2009.05.005. Epub 2009 Jun 10.

PMID:
19520460
10.

Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.

Grool AM, van der Graaf Y, Mali WP, Geerlings MI; SMART Study Group.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1093-100. doi: 10.1136/jnnp.2010.232413. Epub 2011 Apr 1.

PMID:
21459931
11.

Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.

Jochemsen HM, Geerlings MI, Grool AM, Vincken KL, Mali WP, van der Graaf Y, Muller M.

J Alzheimers Dis. 2012;29(1):39-49. doi: 10.3233/JAD-2012-111772.

PMID:
22214784
12.

Cerebral small-vessel disease and decline in information processing speed, executive function and memory.

Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM.

Brain. 2005 Sep;128(Pt 9):2034-41. Epub 2005 Jun 9.

PMID:
15947059
13.

Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study.

Grool AM, van der Graaf Y, Mali WP, Witkamp TD, Vincken KL, Geerlings MI; SMART Study Group.

Psychol Med. 2012 Feb;42(2):359-70. doi: 10.1017/S0033291711001383. Epub 2011 Aug 11.

PMID:
21835088
14.

Arterial stiffness and progression of structural brain changes: The SMART-MR study.

Jochemsen HM, Muller M, Bots ML, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2015 Feb 3;84(5):448-55. doi: 10.1212/WNL.0000000000001201. Epub 2014 Dec 31.

PMID:
25552578
15.

Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: the SMART-MR study.

van der Veen PH, Muller M, Vincken KL, Witkamp TD, Mali WP, van der Graaf Y, Geerlings MI; SMART-MR Study Group.

J Neurol Sci. 2014 Feb 15;337(1-2):112-8. doi: 10.1016/j.jns.2013.11.029. Epub 2013 Nov 27.

16.

How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia.

Pohjasvaara T, Mäntylä R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, Kaste M, Erkinjuntti T.

Arch Neurol. 2000 Sep;57(9):1295-300.

PMID:
10987896
17.

Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study.

Appelman AP, van der Graaf Y, Vincken KL, Tiehuis AM, Witkamp TD, Mali WP, Geerlings MI; SMART Study Group.

J Cereb Blood Flow Metab. 2008 Mar;28(3):633-9. Epub 2007 Oct 3.

PMID:
17912270
18.

Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity -- a 7 T study.

Conijn MM, Hoogduin JM, van der Graaf Y, Hendrikse J, Luijten PR, Geerlings MI.

Neuroimage. 2012 Jan 16;59(2):950-6. doi: 10.1016/j.neuroimage.2011.08.059. Epub 2011 Sep 10.

PMID:
21930217
19.

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.

Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group.

Diabetologia. 2007 Nov;50(11):2388-97. Epub 2007 Sep 2.

20.

Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment.

Grau-Olivares M, Arboix A, Junqué C, Arenaza-Urquijo EM, Rovira M, Bartrés-Faz D.

Cerebrovasc Dis. 2010;30(2):157-66. doi: 10.1159/000316059. Epub 2010 Jun 10.

PMID:
20551631

Supplemental Content

Support Center